Summary. The reproductive performance of Coopworth ewes after administration of zearalenone was determined in two trials. In Trial 1, zearalenone was administered to groups of 33 ewes at rates of 0, 1\m=.\5,3\m=.\0,6\m=.\0,12\m=.\0and 24\m=.\0mg/ewe/day for 10 days, starting on Day 7 of the oestrous cycle before mating. There was a linear decline (P < 0\m=.\001) in ovulation rate with dose of zearalenone; also cycle length decreased and duration of oestrus increased with increasing dose levels. Reductions in the incidence of ovulation and in fertilization were seen only at doses of 12 and 24 mg. In Trial 2, groups of 50 ewes were given the same range of doses of zearalenone for 10 days, starting 5 days after mating to entire rams. There was no effect of zearalenone treatment after mating on pregnancy rate or embryonic loss. These results indicate that the effects of zearalenone, administered orally, on ewe reproduction, at the dose levels examined, were restricted to ewes exposed before mating. Intakes of zearalenone of 3 mg/ewe/day or more during this period would be reflected as depressed ovulation rates and lower lambing percentages.
Introduction
Large-spored fusaria are a common component of the mycoflora of leaves of pasture in the North Island of New Zealand (di Menna & Parle, 1970) . They are present in greatest numbers in late summer and autumn (February to April) , and counts of 104 to 107 Fusarium macroconidia/g wet weight of leaves have been recorded. Some Fusarium spp. produce metabolites which affect animals, among them the F-2 toxin or zearalenone [6-(10-hydroxy-6-oxo-trans-l-undecenyl)-ß-resorcyclic acid-lactone] which has oestrogenic activity (Christensen et ai, 1965) . Zearalenone has often been reported in Fusarium-inÎected grains and feedstuffs prepared from them and also from infected hay (Mirocha et ai, 1968) . Various Fusarium strains isolated from New Zealand pastures have been shown to produce zearalenone when cultured (di Menna et ai, 1985;  Gallagher, 1985) .
There have also been reports of the presence of zearalenone in pasture infected with Fusarium spp.
(di Menna et ai, 1985 Menna et ai, , 1987 .
Zearalenone has oestrogenic properties (Mirocha et ai, 1978; Blankenshipe/ ai, 1982) and detri¬ mental effects on the reproductive performance of sows and cows have been reported (Mirocha et ai, 1968; Kurtz et ai, 1969; Chang et ai, 1979; Long et ai, 1983; . On some New Zealand farms there are unexplained shortfalls in the reproductive performance of ewes and it was thought possible that Fusarium spp., at their peak in pasture at the time ewes are mated, might produce sufficient zearalenone to affect ewe fertility (Jagusch et ai, 1986) . Reports of the effects of zearalenone on reproduction of sheep are sparse and tend to be associated with its effect on the pregnant animal (Mitton et ai, 1975) . The administration of 25 mg zearalenone/ewe/day for 10 days before oestrus caused almost complete disruption of reproduction (Smith et ai, 1986 (Table 3 ) and are illustrated in Fig. 1 . There was no effect ofzearalenone on the incidence of oestrus with all ewes exhibiting oestrus after treatment. However, there was a significant ( < 0001) effect of dose of zearalenone on the proportion of ewes ovulating after treatment with a marked reduction at the higher (120 and 240 mg) dose levels ( Table 1 ). The ovulation rate or number of ovulations per ewe examined was also affected by dose of zearalenone and showed a linear (P < 0001) decline (Table 1; Table 3 ; Fig. 1 ) with increasing dose. This was reflected in the progressive decline in change of ovulation rate with increasing dose of zearalenone (Table 1) . There were no significant effects of zearalenone on the proportion of ewes yielding ova of those ewes ovulating (72-6%) or on the proportion of ewes yielding fertilized ova of those yielding ova (80-7%; Table 1 ).
Zearalenone dose had significant effects on liver weight (P< 0-001), ovary weight (P < 0001) and weight of uterus and oviducts (P < 001) but not on the carcass weight (Table 2) . There was no effect of dose on ewe liveweight after treatment or on liveweight change from before to after treatment. •(•Residuai standard deviation. **P < 001; ***P < 0001. The changes in organ weight had significant linear components of dose (Table 3) . Trial 2. There were no significant effects of dose of zearalenone administered after mating on the proportion of ewes which bore a lamb, number of lambs born or on various measures of embryonic or ova wastage. Of the 300 ewes placed with males 295 survived to lambing time. These ewes had a mean ovulation rate of 1 -93 and 71-5% of them conceived and lambed to the one synchronized cycle of mating with entire rams. There was an average of 1-64 lambs born per ewe lambing (Table 4) .
Subtraction of the number of lambs born from the initial ovulation rate indicates a total ova wastage of 39-5% (Table 5) .
Examination of the cycle length of the 53 ewes exhibiting a return oestrus showed that only 3 ewes (6%) had cycles outside the normal 16-18-day range. These 3 all had 15-day cycles and the ewes were in the 24 mg (1 ewe) and 12 mg (2 ewes) dose groups. The mean cycle length for these 2 groups (16-4 + 0-3 days) was significantly (P < 005) shorter than that for the other groups (17-1 +0-2 days).
Discussion
The virtual absence of zearalenone from the pasture grazed in the two experiments indicates that the effects of zearalenone dosage are unlikely to have been confounded by exposure to pasture zearalenone. The very low levels of Pithomyces chartarum spores also indicate that the results are unlikely to be confounded by sporodesmin toxicity (facial eczema disease), which has been shown to depress ewe fertility (Smeaton et ai, 1985) .
Treatment of ewes before mating with zearalenone markedly affected their reproductive performance, the most noticeable effect being a linear decline in ovulation rate with an increasing dose of zearalenone. At the lower doses this was due to a reduction in the proportion of ewes with multiple ovulations while the higher doses (120 and 240 mg) caused a proportion of the ewes to become anovulatory. The depression in ovulation rate at the high dose is similar to that reported previously for a 25-mg dose (Smith et ai, 1986) . The reduction in numbers of ewes with multiple ovulations at the lower doses is of sufficient magnitude to explain the reduced twinning in ewes grazed on zearalenone-contaminated pastures (Jagusch et ai, 1986 ).
The linear reduction in ovulation rate with increasing dose is similar to that reported for increasing doses of coumestrol (Smith et ai, 1979) . Comparison of those data with the results in the present trial indicates that zearalenone has about 10 times the activity of coumestrol. The most likely mechanism of action, causing the decrease in ovulation rate, is through a reduction in plasma FSH concentrations due to increased oestrogenic negative feedback on the pituitary (Smith et ai, 1987) .
The lack of a significant effect on fertilization rate in the present trial, even at higher doses, contrasts with that reported by Smith et ai (1986) who found a reduction in the number of ewes yielding fertilized embryos when dosed with 25 mg zearalenone, even though similar mating management and ram:ewe ratios were used in both experiments. This is a surprising result consider¬ ing previously reported effects of oestrogen on fertilization and sperm transport (Croker et ai, 1975) and there is no obvious explanation, although these data indicate a tendency for reduced fertility at the higher doses. In neither experiment was there any effect of zearalenone before mating on subsequent embryo recovery rates. The decrease in cycle length and increase in duration of oestrus with increasing dose of zearalenone confirm its oestrogenic action in the ewe (Fletcher & Lindsay, 1971) . This is further supported by the increase in uterine weight and reduction in ovarian weight recorded. Enlargement of the reproductive tract and prolonged oestrous activity has also been reported in sows exposed in zearalenone (Chang et ai, 1979) . However, the shortened cycle length of the ewes contrasts with markedly extended cycles reported for zearalenone-treated sows (Edwards et ai, 1987; Flowers et ai, 1987) although the levels of zearalenone intake were similar. This indicates the possibility of different roles for oestrogen in the luteolytic process of the two species.
The failure of zearalenone, administered between Days 5 and 15 after mating at the dose levels used in Trial 2, to affect the number of ewes pregnant and their lambing rate is a most important finding. It indicates that, under grazing conditions and exposure to zearalenone at the levels reported in New Zealand pasture (di Menna et ai, 1987) , most of the decreased repro¬ ductive performance is due to pre-mating exposure and reduction in ovulation rate. The lack of effect of zearalenone on embryonic loss in the ewe is in marked contrast to that reported for gilts and sows (Long et ai, 1983 (Long et ai, , 1988 in which severe embryonic wastage was observed. This could possibly be a reflection of dose of zearalenone given as, in general, the levels causing the effect in sows were higher than those given to the ewes in the present trial. However in one experiment 
